Andrew JS Coats
Director of the Monash Warwick Alliance and Academic Vice-President
Monash University, Australia and University of Warwick, UK
Professor Andrew Justin Stewart Coats was born in Melbourne, Australia on 1 February 1958. His father was a Professor of Resuscitation who first described essential fatty acids.
He is an Australian-British academic cardiologist as well as a successful fundraiser, university administrator and inventor.
Professor Coats attended Melbourne Grammar School and studied at Oxford and Cambridge.9 He has higher doctorates from Oxford (DM) and Imperial (DSc.) and an MBA from London Business School.1
He obtained a Bachelor of Arts in 1979, a Bachelor of Medicine and Surgery in 1981, a Master of Arts in 1982, a PhD in Management in 1989, became a Doctor of Sciences in 1999 and completed a further Masters in Business Administration in 2001.
He is a Diplomate and Fellow of the Australian Institute of Company Directors and a member of the UK Institute of Directors.1 Professor Coats’ research interests are chronic heart failure, hypertension and organizational behaviour.
His research has greatly influenced the treatment for chronic heart failure, promoting exercise training instead of bed rest. He was instrumental in describing the "muscle hypothesis" of heart failure. This research turned established teaching on its head and promoted exercise training (rather than bed rest) as a treatment for chronic heart failure.3
After completing his medical degree in 1981, Andrew Coats began his career at St Vincent's Hospital, Melbourne. Ten years later, he was appointed Senior Lecturer, supported by the British Heart Foundation, at the National Heart and Lung Institute (NHLI). He was appointed Viscount Royston Professor of Cardiology at Imperial College in 1996 and Director of Cardiology and Associate Medical Director of the Royal Brompton and Harefield NHS trust.9 He was also an honorary consultant physician, Clinical Director for Cardiology and Associate Medical Director at the Royal Brompton Hospital in London.
Professor Coats was appointed Dean of Medicine at the University of Sydney in 2002 and subsequently Deputy Vice-Chancellor.4 Professor Coats was CEO of Norwich Research Park, the UK's oldest and largest research and innovation park. In 2009, Professor Coats was appointed the second Norwich Research Park Professor-at-Large. Concurrently, he was Visiting Professor of Medicine at The University of Sydney in Australia, Consulting Professor for Research Strategy at the Chinese University of Hong Kong and a Guest Scientist at the Charité Medical School of Humboldt University in Berlin.8
In 2017, he was appointed an Officer of the Order of Australia for distinguished service to medical research and tertiary education in the field of cardiology, as an academic and author and as a mentor and role model for young scientists.10
He was the chair of Australia's peak policy body for Health Informatics, the Australian Health Information Council, the New South Wales Ministerial Advisory Committee on Health and Medical Research (MACMHR) and has been on various committees.4 Professor Coats has published two theses, 15 Government reports, 10 textbooks, two Cochrane reviews, over 500 peer-reviewed full papers and has more than 49,000 career citations.5
Professor Coats has both chaired and been a committee member of many large-scale international drug trials that have influenced the treatment of cardiovascular diseases such as the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Trial, OPTIMAAL (angiotensin receptor antagonist in heart failure) and SENIORS (management of heart failure in the elderly).
He has been a board director of a number of private and public companies such as Myotec, PsiOxus, Lone Star Heart Inc, Centenary Institute, the Heart Research Institute, Cardiodirect (UK) Limited, the Woolcock Institute of Medical Research and the George Institute of International Health. He was also Editor-in-Chief of the International Journal of Cardiology for nearly 20 years.
Presently, Professor Coats is serving as Joint Academic Vice-President of Monash University, Australia and the University of Warwick, UK. He is President of the Heart Failure Association of the European Society of Cardiology and is Editor-in-Chief of Cardiac Failure Review.3
- 1991: Senior Lecturer, National Heart and Lung Institute
- 1996 - 2002: Viscount Royston Professor of Cardiology, Imperial College London
- 1998 - 2000: Director of Cardiology, Royal Brompton Hospital
- 1999 - 2015: Editor-in-Chief, International Journal of Cardiology
- 2000 - 2002: Associate Medical Director, Royal Brompton Hospital
- 2002 - 2006: Dean of Medicine, University of Sydney
- 2006 - 2010: Deputy Vice-Chancellor, University of Sydney
- 2009: Second Norwich Research Park Professor-at-Large
- 2009 - 2010: Director, Cardiodirect
- 2010 - 2012: The Norwich Research Park Professor and Chief Executive, NRP and UEA
- 2011 - 2012: CEO, Norwich Research Park
- 2011 - 2017: Director, Lone Star Heart Inc.
- 2013 - 2016: Academic Vice-President (Monash/Warwick Alliance), Monash University
- 2020 - Present: President, Heart Failure Association
- 2020 - Present: President-Elect, Presidential Trio of the Heart Failure Association of the ESC
- Present: Editor-in-Chief, Cardiac Failure Review
- 1998: Linacre Medal of the Royal College of Physicians
- 1999: The Inaugural Michael L Pollock Award, American Heart Association
- 2010: Gold Heart Award, American Heart Association
- 2017: Officer of the Order Of Australia
Areas of Speciality1
- Chronic heart failure
- Organizational behaviour
Prof Coats is Editor-in-Chief of the Cardiac Failure Review editorial board.